These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16954793)

  • 1. Muscarinic receptors in the ocular surface.
    Enríquez-de-Salamanca A; Calonge M
    Curr Opin Allergy Clin Immunol; 2006 Oct; 6(5):379-82. PubMed ID: 16954793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptor agonists and antagonists: effects on ocular function.
    Mitchelson F
    Handb Exp Pharmacol; 2012; (208):263-98. PubMed ID: 22222703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
    Eglen RM
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor ligands and their therapeutic potential.
    Eglen RM; Choppin A; Dillon MP; Hegde S
    Curr Opin Chem Biol; 1999 Aug; 3(4):426-32. PubMed ID: 10419852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium.
    Enríquez de Salamanca A; Siemasko KF; Diebold Y; Calonge M; Gao J; Juárez-Campo M; Stern ME
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):504-13. PubMed ID: 15671275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of muscarinic receptor subtypes on human cornea and conjunctiva.
    Liu S; Li J; Tan DT; Beuerman RW
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2987-96. PubMed ID: 17591863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and pharmacological characterization of muscarinic receptors in retinal pigment epithelium: role in light-adaptive pigment movements.
    Phatarpekar PV; Durdan SF; Copeland CM; Crittenden EL; Neece JD; García DM
    J Neurochem; 2005 Dec; 95(5):1504-20. PubMed ID: 16269010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic receptor subtypes in the alimentary tract.
    Tobin G; Giglio D; Lundgren O
    J Physiol Pharmacol; 2009 Mar; 60(1):3-21. PubMed ID: 19439804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic submandibular effects and muscarinic receptor expression in blood vessels of the rat.
    Ryberg AT; Selberg H; Soukup O; Gradin K; Tobin G
    Arch Oral Biol; 2008 Jul; 53(7):605-16. PubMed ID: 18329001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic acetylcholine receptors as CNS drug targets.
    Langmead CJ; Watson J; Reavill C
    Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor agonists and antagonists: effects on inflammation and immunity.
    Verbout NG; Jacoby DB
    Handb Exp Pharmacol; 2012; (208):403-27. PubMed ID: 22222708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and distribution of cholinergic receptors in the human urothelium.
    Bschleipfer T; Schukowski K; Weidner W; Grando SA; Schwantes U; Kummer W; Lips KS
    Life Sci; 2007 May; 80(24-25):2303-7. PubMed ID: 17335853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line.
    Cabadak H; Küçükibrahimoğlu E; Aydin B; Kan B; Zafer Gören M
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):109-15. PubMed ID: 19364336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man.
    Ryberg AT; Warfvinge G; Axelsson L; Soukup O; Götrick B; Tobin G
    Arch Oral Biol; 2008 Jan; 53(1):66-74. PubMed ID: 17825245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.
    Greig NH; Reale M; Tata AM
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):123-41. PubMed ID: 23597304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptor subtypes in the lower urinary tract.
    Giglio D; Tobin G
    Pharmacology; 2009; 83(5):259-69. PubMed ID: 19295256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice.
    Yamada S; Maruyama S; Takagi Y; Uchida S; Oki T
    Life Sci; 2006 Dec; 80(2):127-32. PubMed ID: 16996089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic muscarinic receptors: new opportunities to treat psychiatric disorders.
    Dean B
    Future Med Chem; 2013 Sep; 5(13):1547-9. PubMed ID: 24024946
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes.
    Zhang HM; Chen SR; Pan HL
    J Neurophysiol; 2007 Jan; 97(1):102-9. PubMed ID: 17050831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.